Treatment Pathways and Health Outcomes of German Patients with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Health Claims Data Analysis.
Christof ScheidRobert KudernatschMarie EckartChiara FeigVincent StraubBerit LibutzkiJoerg MahlichPublished in: Drugs - real world outcomes (2022)
Findings from this study reveal a high disease burden associated with cGvHD. This underlines the high medical need for new interventional strategies to improve survival and morbidity after allo-HCT.